ICON Public (NASDAQ:ICLR) Cut to “Neutral” at The Goldman Sachs Group

The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a research note released on Friday, Marketbeat reports. The Goldman Sachs Group currently has $200.00 price objective on the medical research company’s stock, down from their prior price objective of $250.00. Other equities […]

Leave a Reply

Your email address will not be published.

Previous post OptiNose’s (OPTN) Neutral Rating Reiterated at HC Wainwright
Next post Super Micro Computer (NASDAQ:SMCI) Upgraded at JPMorgan Chase & Co.